Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why Traders Are Watching These Five Stocks Today

Page 1 of 2

The US stock markets gained ground further on Thursday morning as market volatility after Brexit continues to subside. Investors also await an important speech by key Federal Reserve policy maker James Bullard.

Several stocks are worth watching today, including Opko Health Inc. (NASDAQ:OPK), Transition Therapeutics Inc (USA) (NASDAQ:TTHI), Ally Financial Inc (NYSE:ALLY), Darden Restaurants, Inc. (NYSE:DRI) and McCormick & Company, Incorporated (NYSE:MKC). Let’s find out why these stocks are in the spotlight today and also analyze the hedge fund sentiment towards them.

Hedge fund sentiment is an important metric for assessing long-term profitability. At Insider Monkey, we track over 760 hedge funds, whose quarterly 13F filings we analyze to determine their collective sentiment towards several thousand stocks. However, our research has shown that the best strategy is to follow hedge funds into their small-cap picks. This approach can allow monthly returns of nearly 95 basis points above the market, as we determined through extensive backtests covering the period between 1999 and 2012 (read more details here).

Most Ethnically Diverse Cities in America

Kobby Dagan / Shutterstock.com

Opko Health to Acquire Transition Therapeutics

Opko Health Inc. (NASDAQ:OPK) and Transition Therapeutics Inc (USA) (NASDAQ:TTHI) are in the spotlight today after both companies announced an agreement under the terms of which Opko Health will acquire Transition Therapeutics for approximately $60 million, or $1.55 per share. In a statement, CEO of Opko, Phillip Frost, M.D., said that the acquisition provides Opko with multiple drugs with heavy potential and added that Opko is “ideally positioned” to leverage Transition Therapeutics’ clinical programs and bring them to market for the benefit of patients. A total of 16 hedge funds from our database were bullish on Opko Health Inc. (NASDAQ:OPK) at the end of the first quarter, while only four funds held shares of Transition Therapeutics Inc (USA) (NASDAQ:TTHI).

Follow Opko Health Inc. (NYSE:OPK)
Trade (NYSE:OPK) Now!

Ally Financial Passes Fed’s Stress Test

Ally Financial Inc (NYSE:ALLY)’s stock has gained over 2% so far today after passing the US Federal Reserve’s annual stress test on Wednesday. After the approval, the bank is free to pay a dividend of $0.08 per share and conduct a buyback of $700 million. The Federal Reserve’s stress test was adopted after the 2008 financial crisis to judge a company’s capability to withstand a major economic downturn. The Michigan based financial services company’s common equity Tier 1 ratio was 5.2%, above the Fed’s minimum required level of 4.5%.  Stephen Feinberg’s Cerberus Capital Management is one of 51 hedge funds from our database that reported stakes in Ally Financial Inc (NYSE:ALLY) as of the end of the first quarter.

Follow Ally Financial Inc.
Trade (ALLY) Now!

On the next page, we will take a loot at today’s stock movements of Darden Restaurants and McCormick.

Page 1 of 2
Loading Comments...